GLP-1 receptor agonists lead a new wave of therapeutic options that may benefit patients with osteoarthritis, according to ...

This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

Researchers at Ruhr University Bochum, Germany, identified a receptor that plays a crucial role in stress-induced motor ...

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research ...

GLP-1 receptor agonists have long half-lives so a patient would need to stop taking it a month before a scan for it to completely eliminate the risk of it influencing the imaging. Gadaleta noted that ...

Efficacy of tirzepatide does not differ significantly between men and women, despite sex-specific differences in ...

Researchers at Leipzig University and Martin Luther University Halle-Wittenberg have investigated a previously unknown ...

People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems.

This 3-part series looks at the evidence for the treatment of SUDs reviews & the use of GLP-1 receptor agonists and alcohol use disorder.

Marketing and manufacturing practices for compounded GLP-1RA drugs have come under FDA scrutiny, prompting policy changes.

When it comes to brain proteins, small changes can make a dramatic difference. Researchers studying NMDA ...